PubMed دسترسی آزاد

High-throughput in silico multi-epitope reverse vaccine design against hydatidosis.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

The Middle East is a significant hotspot for human hydatidosis caused by Echinococcus granulosus, a complex multi-stage pathogen exhibiting antigenic variation with diverse epitopes. Multi-epitope vaccines, designed using immunoinformatics, represent a promising approach to effectively control this challenging parasite. A total of 1150 secreted, non-toxic, antigenic proteins were obtained from database and analyzed for their immunogenic potential, leading to the identification of 1024 CTL, 80 HTL, and 172 LBL prioritized epitopes, which were then ranked and clustered to prefer the most immunogenicity epitopes to include in novel vaccine construct. The chosen Construct (Con2) was modified for dual-plasmid insertion, facilitating the expression of three different vaccine constructs which were predicted by C-ImmSim to stimulate robust IFN-γ/IL-2 production and enhance IgM/IgG antibody secretion. Utilizing in silico, next-generation vaccine design, we propose several vaccine candidates that warrant further validation through in vitro laboratory testing and in vivo studies to assess their immunological efficacy.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

Echinococcus granulosusEpitopes predictionImmunoinformaticIn silico cloningMulti-epitope vaccines
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Barry Bloom and the convergence of immunology, infectious disease, and public health.

In early 2026, the world lost Barry Bloom, a great advocate for public health, an extraordinarily accomplished immunologist, and a science advisor who helped refocus policy on controlling infectious diseases, including neglected diseases such as leprosy. Barry's career took him from a life of laboratory discovery where he was enormously influential in catalyzing the late 20th century shift from studying the immune response of simple mo…

PubMed2026

Trajectories in immunometabolism.

Immunometabolism has rapidly evolved from an emerging area within immunology into a topic that not only impregnates most aspects of immune research but also reveals itself as a defining feature of the immune response. At the European Immunometabolism Conference celebrated in June, we asked some of the speakers to share their personal journey as researchers in this field and what questions they are currently working on.

PubMed2026

Hazy mysteries and the major histocompatibility complex: a journey.

I was pleased to receive an invitation to write a historical perspective on my career. As I understand it, these perspectives aim to illustrate the often-twisted paths to discoveries, the fortuitous events that often enable them, and the pitfalls along the way. At the same time, they can be expected to illustrate the influence of the particular "tastes" and interests of a scientist in the choices that are made along the way and that th…